Startups

Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers


Aktis Oncology, a Massachusetts startup developing targeted radiation drugs for cancer, has raised $84 million in new funds from Merck & Co’s venture …

Read more

Show More

Related Articles

Back to top button